Digitek Recall

Free Case Evaluation

Actavis Totowa Issues CLASS1 NATIONWIDE RECALL of Digitek
(digoxin tablets, USP, all strengths)

April 29, 2008, manufacturers of Digitek, issued a recall of all strengths of its oral tablets. The U.S. Food and Drug Administration (FDA) deemed the Digitek recall a Class I Recall. Class I recalls are conducted when dangerous or defective products that predictably could cause serious health problems or death are released.

Digitek is used to treat abnormal heart rhythms and heart failure. Mylan Pharmaceuticals Inc. distributes Digitek under a “Bertek” label and is also distributed by UDL Laboratories Inc, under a “UDL” label. The all-lot recall is due to the possibility that tablets with double the appropriate thickness may have been released. Double strength tablets could result in an elevated risk of digitalis toxicity in patients with renal failure.

Digitalis toxicity side effects can include:

• Low blood pressure
• Dizziness
• Cardiac instability
• Bradycardia (a heart rate below 60bpm)
• Irregular or slow heartrate
• Can lead to death

PLEASE DO NOT STOP TAKING ANY PRESCRIPTION DRUG, INCLUDING DIGITEK, UNTIL YOU HAVE FIRST SPOKEN TO YOUR DOCTOR.

Contact the Law Offices of d'Oliveria & Associates, P.C.

If you believe that you or a loved one has suffered serious injury or death as a result of taking Digitek, you may want to speak with a personal injury attorney regarding a potential lawsuit. An injury lawyer familiar with new developments in the investigation of Digitek may be able to help you make important personal and legal decisions.

Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.